Ionis Pharmaceuticals Files 8-K on Shareholder Votes & Financials
Ticker: IONS · Form: 8-K · Filed: Jun 10, 2025 · CIK: 874015
Sentiment: neutral
Topics: sec-filing, corporate-governance, financial-reporting
TL;DR
IONIS filed an 8-K on June 10th covering shareholder votes and financials as of June 5th.
AI Summary
Ionis Pharmaceuticals, Inc. filed an 8-K on June 10, 2025, reporting on matters submitted to a vote of security holders and financial statements as of June 5, 2025. The filing details the company's principal executive offices located at 2855 Gazelle Court, Carlsbad, CA 92010.
Why It Matters
This filing provides essential updates on corporate governance and financial reporting for Ionis Pharmaceuticals, Inc., which is crucial for investors to understand the company's operational status and shareholder engagement.
Risk Assessment
Risk Level: low — This is a routine SEC filing (8-K) reporting on corporate matters and financial statements, not indicating any immediate operational or financial distress.
Key Numbers
- 000-19125 — SEC File Number (Identifies the company's filing history with the SEC.)
- 33-0336973 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- IONIS PHARMACEUTICALS, INC. (company) — Registrant
- June 5, 2025 (date) — Earliest event reported
- June 10, 2025 (date) — Date of report
- 2855 Gazelle Court, Carlsbad, CA 92010 (location) — Principal Executive Offices
- ISIS PHARMACEUTICALS INC (company) — Former company name
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in the excerpt.
What financial statements are being reported?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific financial statements are not detailed in this excerpt.
When was the company formerly known as ISIS PHARMACEUTICALS INC?
The date of the name change from ISIS PHARMACEUTICALS INC to IONIS PHARMACEUTICALS, INC. was March 28, 1993.
What is the primary business of Ionis Pharmaceuticals, Inc. according to the SIC code?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to 'PHARMACEUTICAL PREPARATIONS'.
In which state was Ionis Pharmaceuticals, Inc. incorporated?
Ionis Pharmaceuticals, Inc. was incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 10, 2025 regarding IONIS PHARMACEUTICALS INC (IONS).